Keywords: galenica, sees, 1st-half, sales/profits, growth, switzerland, posted
Galenica sees 1st-half sales/profits growth
Article | 10 September 2001
Galenica of Switzerland has posted a 4.1% rise in first-half 2001 groupturnover to 1.05 billion Swiss francs ($628.9 million), while operating profit was up 8% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
